Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.
The BVA and the RCVS are inviting applications from veterinary surgeons to join the new Vet Futures Action Group, set up to drive forward the ambitions identified in the Vet Futures report launched at BVA Congress at the London Vet Show on 20 November.
The Vet Futures report, Taking charge of our future: A vision for the veterinary profession for 2030, was the culmination of a year-long joint project by BVA and RCVS designed to help the veterinary profession prepare for, and shape, its own future. The Action Group is a vital next step in the Vet Futures project, ensuring the delivery of the report’s six ambitions and 34 recommendations.
BVA and RCVS are seeking seven veterinary surgeons and one veterinary nurse to join the Action Group to ensure there is buy-in from across the professions and to drive forward workstreams of activity. The group will be co-chaired by the BVA and RCVS Presidents, and both Junior Vice-Presidents will sit on the group. Action Group members will be independent and will not represent, or be required to report back to, any particular organisation.
Veterinary surgeons or nurses keen to apply for an Action Group role should have experience of working as an active member of a group or committee and the ability to deliver, engage and inspire others. The veterinary surgeon members should have specific expertise, knowledge and experience in relation to at least one of the Vet Futures ambitions or the cross-cutting issue of veterinary education. The ambitions cover:
Successful applicants must be able to attend three all-day meetings in London (9 February, 17 March and 12 May) and an all-day Vet Futures Summit (20 June), with a time commitment totalling approximately seven days between February and June 2016. The group will be supported by BVA and RCVS staff. For the full Vet Futures Action Group role profile and terms of reference, please visit: www.vetfutures.org.uk.
The deadline for applications is 12 noon, 31 December 2015.
Pets’n’Vets has announced that it is burying a veterinary time capsule under its new Roundhouse Veterinary Hospital being built on the southside of Glasgow.
Brainchild of Pets’n’Vets partner Ross Allan, the idea is that the capsule will reveal to future generations how the cutting edge veterinary facility in Glasgow looked in 2015 and help show just how far veterinary science has developed when it is opened in 2115.
Ross said: "The aim of the time capsule is to document the memories, hopes and dreams of our staff at this exciting point in our story, and preserve them as best we can for discovery in 100 years."
The capsule, which was curated with help from The Veterinary History Society and the British Library, contains:
Ross said: "As an orthopaedic surgeon, I’m used to dealing with cutting edge metal plates, screws and pins when fixing fractured legs, but helping develop this capsule was an entirely new challenge for me. It is very rewarding to use great science to preserve these memories as best we can.
"The time capsule has been designed with this in mind: maintaining optimal humidity, zero oxygen and steady temperature. It will be welded shut before being flushed with argon gas, all measures to help preserve the photos, letters and other contents for those that are lucky enough to open it."
In order preserve the contents as best as possible, Ross sought the advice of Glasgow Museums, which advised including archive quality paper and ink to prevent fading of writing and images, as well as the use of corrosion bags to contain the metallic surgical implants.
"I thought it would be fun to include the implants we currently use for cruciate surgery," said Ross. "This is one aspect of veterinary surgery that has especially progressed over the last 30 years and will doubtlessly continue to progress in the years ahead."
David Thomson, Preventative Conservation Officer, Glasgow Museums, added: "Sending things safely into the future is very like preserving the collections we have in the Museum. The Veterinary Time Capsule meets the highest standards for slowing down the normal ageing effects of our environment and we wish it well on its journey through time."
The time capsule has been registered with the International Time Capsule Society (ITCS) at Oglethorpe University, Atlanta, USA.
Ross said: "This will ensure the capsule is followed up and not, like the majority, lost forever," said Ross. "When opened, the contents should offer a snapshot into Scottish 21st Century veterinary medicine and perhaps it can offer a small legacy to the future of veterinary medicine too.
"Veterinary medicine is going through a huge transition at present – the scope of what is available today is poles apart from what was possible even 10 years ago – and we are delighted to help document its development in Glasgow to this point. Just what might be possible when the capsule is opened in 2115 is mind boggling!"
CVS has announced the official opening of Lumbry Park Veterinary Specialists, a new small animal referral hospital in Alton, Hampshire.
The hospital was officially opened last Saturday by the Town Mayor of Alton during an open day attended by local dignitaries, about a hundred vets and representatives from the veterinary industry and various animal charities. Dr Caner Salih, a consultant cardiac surgeon at the Evelina London Children's Hospital was a special guest.
CVS says it has invested more than £4.3 million to create one of the most advanced, multi-disciplinary specialist veterinary hospitals in the UK. It occupies 1,300 square metres and employs forty people, including nine referral clinicians (seven of whom are boarded specialists), support and admin staff.
Lumbry Park offers a range of advanced diagnostics and treatments for dogs and cats across a range of specialties, including high-field MRI and CT scanning, key-hole surgery, interventional cardiac procedures, and joint replacements. Cardiology specialist Dr Luca Ferasin is Lumbry Park's Clinical Director, reporting to Professor John Innes, CVS' Referral Director.
Simon Innes, Chief Executive of CVS, pictured fifth from left, said: "The opening of Lumbry Park is a proud moment for CVS and the culmination of a huge amount of work by John, Luca and the team involved. They have worked together to create a fantastic environment in which our specialists can offer the highest standard of veterinary care to our patients and their owners and we are delighted to bring their expertise to veterinary practices and their clients right across the South East of England."
CVS Referral Director, Professor John Innes said: "The opening of Lumbry Park marks a major step for CVS in terms of investment in veterinary specialist services and we will work to ensure that it develops an international reputation for the standard of care it provides. The Hospital is easily accessible and has the space and rural setting to provide a professional and pleasant environment for our patients, their owners, and our team. Luca and his excellent team are raring to go and we look forward to welcoming our first patients next week."
Alton Town Mayor Mrs Pam Jones added: "I am delighted that Alton has been chosen as the location for such a prestigious veterinary centre and I am honoured to be asked to open it."
The University of Glasgow, School of Veterinary Medicine, is calling for help with research into the prevalence of pseudopregnancy in spayed bitches.
The research takes the form of a survey being conducted amongst a representative sample of veterinary surgeons by Pippa Hutchison, Dr Tim Parkin, Caroline Warnes and Dr Philippa Yam.
In particular, the research aims to gather data looking into how often veterinary surgeons are diagnosing and treating pseudopregnancy, and how frequently the condition occurs both before and after spaying.
Tanya Leslie MRCVS from Ceva Animal Health, sponsors of the work, said: “Ceva is delighted to have been given the opportunity to support this work to investigate and raise awareness of this important issue”.
The questionnaire is being sent out towards the end of this month. If you're one of the recipients, there's the added incentive of being entered into a draw for a £300 cash prize if you complete the questionnaire and return it by the 13th November.
The researchers say that after this initial work, they plan a prospective study establishing the wider incidence of pseudopregnancy in both entire and spayed bitches.
The RCVS is seeking applicants for an Appointment Group which will be responsible for deciding the membership for the governing body of the new RCVS Fellowship.
In June, RCVS Council approved proposals to develop a new style Fellowship to move it away from being an examination-based award to a formal learned society with routes to entry for those veterinary surgeons who can demonstrate meritorious contributions to clinical practice, to the profession or to learning. The Fellowship by thesis route has been discontinued as of 1 August 2015, although all applications received by this route prior to that date are being processed.
The new Fellowship will be governed and administered by a Fellowship Board with an additional Credentials Panel of up to 30 members to review new applications.
The College says it is now in the process of putting together an Appointment Group which will decide the membership of the Fellowship Board and the Credentials Panel. It is currently seeking to appoint a veterinary surgeon in the earlier stage of their career to the Group. The full details of the role, including details of the person specification, how to apply and information on expenses and remuneration can be found at www.rcvs.org.uk/workforus
The Group will be chaired by former RCVS President Lord Trees with other members being RCVS President Dr Bradley Viner and BVA President Sean Wensley as well as a lay observer. The first meeting of the Appointment Group is likely to take place before the end of the year and, once the Fellowship Board and Credentials Panel are established, the Group will be dissolved.
For an informal chat about the role before applying, contact Dr Simon Wallace, RCVS Education and Scientific Officer, on s.wallace@rcvs.org.uk or 020 7202 0702.
Her Majesty The Queen has today opened the University of Surrey's new £45m School of Veterinary Medicine, accompanied by His Royal Highness The Duke of Edinburgh.
Her Majesty and His Royal Highness toured the Large Animal Clinical Skills Building, where they met students taking equine examinations and working with livestock. The Royal Party also viewed a demonstration in the Biomechanics Laboratory, meeting Professor Noel Fitzpatrick and dogs that have benefitted from prosthetic limb surgery. They also watched teaching sessions in the Clinical Skills Laboratory, meeting staff and students.
After the tour, The Queen, The Duke and assembled guests attended a short ceremony to celebrate the opening of the new teaching facilities, during which Her Majesty unveiled a plaque to mark the occasion.
As The Royal Party left, they were bid farewell by Joey, the star of the theatre production War Horse.
Professor Michael Kearney, Vice-Chancellor of the University of Surrey, said: “We are hugely honoured to welcome Her Majesty and His Royal Highness to the University of Surrey. This is a very special occasion that tops off an exceptional start to the academic year for the University, after the launch of our 5G Innovation Centre and achieving The Times and Sunday Times ‘University of the Year’ accolade.
“The School of Veterinary Medicine further cements our position as a world-class institution that is delivering cutting-edge teaching and research from state-of-the-art facilities. It will not only provide the next generation of sought-after veterinary graduates, but it will offer significant opportunities for collaboration between human and animal medical science professionals and public sector organisations.”
Professor Noel Fitzpatrick, one of the founding partners of the School of Veterinary Medicine, said: “I had a vision where we would deliver a degree structure which was truly focussed on what you dream about when you are sixteen years old, when you are desperate to become a vet. I fully intend to be part of a team that will kindle that fire throughout professional life to shine a light onto the world that badly needs ambassadors of purpose and integrity to be the caretakers of health on Earth, both now and for long after I’m gone and these new buildings will still be standing. This is our legacy, and we are intensely proud to be part of this evolution in health education.”
The RCVS Disciplinary Committee has reprimanded Gloucestershire veterinary surgeon Adele Lewis for failing to pass on information about a horse’s clinical history to a potential buyer during a pre-purchase examination.
Ms Lewis, the sole principal of the Cotswold Equine Clinic in Lechlade, Gloucestershire, carried out the examination of a pony called Luke on 13 February 2014. Luke was owned by Mrs Booth who was a long-established client of Ms Lewis, both at her previous practice, Bourton Vale, and at her current practice. The examination was carried out on behalf of the prospective purchaser, Mrs Grieve.
Upon examination Ms Lewis certified that, in her opinion, Luke’s veterinary history did not increase the risk of purchase.
Following the purchase of Luke, Mrs Grieve attempted to obtain insurance for Luke and found out from a pet insurance company that a claim had been made by Mrs Booth in September 2013. She subsequently found out that, following concerns expressed by Mrs Booth and her trainer about Luke’s movement and their wanting an expert opinion, Ms Lewis had referred him to Dr Kold, a Specialist in Equine Orthopaedics, in September 2013. Dr Kold had diagnosed Luke with lameness and had given him intra-articular medication. Luke had also had a follow-up appointment with Dr Kold about four weeks later in October 2013.
The Disciplinary Committee hearing commenced on Tuesday 13 October 2015. At the outset, Ms Lewis admitted several parts of the charges (charge A and charge B) against her. In regards to charge A, she admitted that she had failed to inform Mrs Grieve that, when she examined Luke on 24 September 2013, his then owner Mrs Booth had complained firstly that Luke was “not tracking up and going forward” and, secondly, that he had improved significantly when put on a Phenylbutazone trial. She also admitted that she had referred him to Dr Kold for a poor performance investigation and that she ought to have informed Mrs Grieve of these matters.
In regards to charge B, she admitted that she completed a Certificate of Veterinary Examination in which she had declared that Luke’s veterinary history did not increase the risk of purchase and allowed the vendor’s declaration to include assertions that there had been no previous lameness and no intra-articular medication given in the last 12 months. Ms Lewis admitted that she ought to have known that her declaration that Luke’s veterinary history did not increase the risk of purchase was incorrect.
However, Ms Lewis denied being aware that Dr Kold had diagnosed lameness, administered an intra-articular corticosteroid to Luke and examined and noted a problem with his breathing, including upper airway disease and possible lower airway disease. Furthermore, she denied dishonesty in regards to both the charges against her and in relation to vendor declarations made on the Certificate of Veterinary Examination regarding previous lameness and intra-articular medication.
During the course of the hearing, Ms Lewis told the Committee that she had not received the reports about the two consultations by Dr Kold (despite their having been sent to her by letter and, with respect to the second report, also by email) and that she was therefore unaware of his findings when she carried out the pre-purchase examination. She also stated that she had not been informed of these by Mrs Booth. During her evidence, Ms Lewis also admitted having entered inaccurate information on a veterinary report to assist with an insurance claim.
The Committee did not find Ms Lewis to be an impressive witness citing the fact that her “explanations as to her practice showed a worrying absence of probity in the completion of veterinary reports for the purposes of insurance claims, and an absence of any effective practice management, consistent with acceptable practice.”
However, the Committee felt it did not have the evidence to conclude that Ms Lewis had acted dishonestly during the pre-purchase examination. It cited the fact that her actions, when informed by the purchaser Mrs Grieve of Dr Kold’s examination, did not appear to be those of someone trying to cover their tracks.
In regards to charge A, the Committee also found that the “apparently chaotic manner in which Ms Lewis ran her practice, and her own opinion that the pony was sound, would appear to have led her to wrongly disregard these matters from disclosure.”
In making its decision on her conduct and sanction, the Committee said that Ms Lewis’ failure to fully communicate to Mrs Grieve all the relevant information about Luke’s veterinary history fell far short of the conduct expected from a veterinary surgeon. It also cited the utmost importance of a complete and accurate certification process, as made clear in the RCVS Code of Professional Conduct and the Twelve Principles of Certification.
Chitra Karve, chairing the Committee and speaking on its behalf, said: “The Committee continues to emphasise the importance of maintaining the integrity of veterinary certification in any aspect of practice. Mrs Grieve told this Committee that if she had been fully informed about Luke’s veterinary history she would not have purchased the pony. It is clear from the evidence that it affected Mrs Grieve’s ability to insure the pony. Ms Lewis has accepted that the information about Luke’s veterinary history, not having been disclosed, was capable of affecting the risk of purchase. The public are entitled to rely upon veterinary surgeons providing complete and accurate information, when certificates and reports are prepared.”
In mitigation, the Committee paid regard to Ms Lewis’ inexperience at running her own practice and found no issue with her competence or clinical ability as a veterinary surgeon. It concluded that she had acted out of character and that there was no financial motivation for her actions. It also found it “highly relevant that the facts admitted and found proved related to a single pre-purchase examination.”
It also noted that Ms Lewis has now put in place a practice management system and has shown insight into her actions, by taking active steps to better comply with her obligations under the Code of Professional Conduct. She had also made early admissions of guilt and made a full apology to both Mrs Grieve and the RCVS both at the outset of the hearing, and in her evidence.
Chitra Karve added: “Having had the opportunity of observing her demeanour at this hearing, the Committee believes that it is unlikely that she will repeat her conduct.... The Committee has concluded that an appropriate and proportionate response in this case is to reprimand Ms Lewis.”
The Society of Practising Veterinary Surgeons (SPVS) is putting out a last call to take part in the SPVS Salaries Survey 2015, open to everybody working in the veterinary profession.
The long-standing survey provides a benchmark for veterinary surgeons, nurses and support staff to see trends in pay and conditions. Designed to provide a complete picture of remuneration levels, the survey covers basic earnings, bonuses, dividends, overtime and benefits such as accommodation, car allowances, private medical insurance and pensions. It also includes questions on employment contracts, hours worked, out of hours and weekend working.
Peter Brown, SPVS Treasurer and author of the Salaries Survey said: “I have been compiling the survey results for a number of years but it never fails to enlighten me as to what is happening in the profession. I know it is also the go to reference guide when practices are recruiting to help ensure they are offering competitive salary packages.
“Participation in the survey is open to all and the more practices that take part, the more accurate and useful the information will be so we would urge everyone working in the veterinary profession to take a few minutes to complete the survey. It can be done online and the information is completely anonymous.”
To complete the survey online, visit www.spvs.org.uk or, for a printed version, telephone 01926 410545. The survey is open until 30 November 2015.
Norbrook has launched an Android version of its existing free iPhone app: ‘the Veterinary Excellence Tool’ (VET).
VET offers a range of functions to assist veterinary professionals and farmers including a product dosing calculator. The Android version has been developed to meet customer demand and has the same features as the Apple version which is available for both iPhones and iPads.
Norbrook highlights the following features of the app:
The app can be downloaded for free by searching for “Norbrook” in either app store.
For further information please contact Laura Holmes, E-Marketing Manager, laura.holmes@norbrook.co.uk or 01536 741147.
BCF, Instrumentation Concept and VetSonic have collected 'VetSurgeon.org Best Stand Awards'; the first two at BEVA Congress and the latter at BCVA Congress.
Judging for the BEVA Congress awards was undertaken by members of BEVA Council. BCF picked up the Best Large Stand Award which was presented by outgoing President, Andrew Harrison.
Pictured left to right: BEVA President, Andrew Harrison, Gavin Mitchell and Carole Irvine of BCF, and John Alborough representing VetSurgeon.org.
Instrumentation Concept picked up the Best Shell Scheme Award
Pictured left to right: Outgoing BEVA President, Andrew Harrison; Tahir Afzac of Instrumentation Concept; John Alborough representing VetSurgeon.org, and Sheraz Ishaque of Instrumentation Concepts
At BCVA Congress, Vetsonic won the Best Stand Award.
Pictured left to right: Clare Walsh, Vetsonic Director; John Alborough, All Round Good Egg representing VetSurgeon.org; Gareth Hateley, then President BCVA and Sarah Vermont, Marketing Manager Vetsonic.
Boehringer Ingelheim has announced the winners of its 16th annual awards for students who have shown the best aptitude for cardiology, orthopaedics and anesthesia over the course of the entire final year.
Bethan MacKenzie, Jennifer Scully, Emma Foster (pictured right with Tim Bentall from Boehringer) and Chris Middleton from The Royal (Dick) School of Veterinary Studies in Edinburgh picked up the awards after being nominated by the respective heads of departments at the college.
The prizes are awarded after discussion amongst all the staff involved with the rotation, specialist surgeons, residents receiving advanced training and the nursing staff. Each winner was awarded a book on veterinary medicine.
VetSurgeon.org has today launched 'Claim CPD', a new feature which allows members to claim time spent on the site towards the annual requirement for 35 hours documented Continuing Professional Development.
The system has been designed to make recording CPD-qualifying activity, both reading or viewing content and participating in forum discussions, as quick and easy as possible.
Clicking the 'Claim CPD' button towards the top right of a content page on VetSurgeon.org reveals a drop down box into which you tap in the time you've spent on the subject, together with optional notes to remind you what you learned and how you plan to put it into practice.
In your VetSurgeon.org profile, there's a new tab marked 'CPD', visible only to you. Click that to reveal a list of all the time you've accrued, with links back to the content you've recorded towards your CPD. You can also produce a certificate covering the time you've logged in a given period, and upload it to your RCVS PDR.
Claim CPD can be used in various sections of VetSurgeon.org:
FORUMS Now there's more reason than ever before to join forum discussions, ask questions and help each other, because when you learn something in the process, you can record it towards your CPD allowance.
NEWS You may not think it's worth recording the short period of time you spent reading a news story on VetSurgeon.org as CPD. But if the story prompted you to spend time finding out more information, it probably is. For example, say you read about a new POM. You spend a couple of minutes reading about it on VetSurgeon.org. But then you visit the manufacturer's website to learn more about it and discuss it with the Territory Manager. Now it has become a worthwhile amount of time to record.
CPD Claim CPD can also be used to record and claim time spent at any event listed in our CPD and Events Diary. So now you can RSVP to the event AND claim a certificate afterwards. Of course, most of the providers supply their own certificates, but useful for when they don't and if you should misplace your certificate.
GALLERIES Now you can claim any time spent watching videos in the VetSurgeon Galleries towards your CPD requirement (indeed, this new feature was inspired by a veterinary surgeon who contacted us to ask for a certificate for precisely that). In addition, if you contribute a clinical image to our curated galleries, and learn something from the curator's comment, you can claim that too.
Arlo Guthrie, VetSurgeon.org Editor said: “I often hear members remark almost guiltily about how much time they spend on VetSurgeon.org. Now there's no need to feel guilty! Sharing knowledge amongst yourselves in forums has always been a great way to learn, recognised by the RCVS. But now, we've made it really easy to document what you've learned, in good time for the requirement to document all CPD from the start of next year."
Virbac has announced that its recently launched parasiticide Neoprinil has been granted a shelf life extension from one to two years after first opening.
The company says the extension will help minimise the risk of wasted product and increase its convenience to farmers.
An eprinomectin pour-on solution, Neoprinil is indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles. It is administered using the company's Farmpack and Flexibag, and offers a zero-day withdrawal period in milk.
Virbac's Product Manager for Large Animals Brigitte Goasduf MRCVS said: "Understanding the challenges our customers face and offering products to overcome them is our goal so we are delighted that Neoprinil has received a shelf life extension because this adds to its flexibility and convenience for farmers. It also brings it into line with Deltanil, our deltamethrin-based pour-on for use against a range of ectoparasites in cattle and sheep.
"We now offer a comprehensive and flexible parasiticide range administered with a dispensing system that sets a new standard for convenience and ease of use."
Neoprinil is presented in 2.5l, 4.5l and 8l pack sizes.
RSA has announced the rollout of its UK-wide network of preferred referral practices.
The scheme caused widespread concern within the profession when it was trialed in the Midlands earlier this year, primarily because of fears that it would reduce general practitioners' freedom to refer an animal to a centre that they felt could provide the most appropriate care for both the animal and the owner. In addition, RSA's claim that it was aiming to provide like-for-like care at a lower cost was undermined by the fact that the network could hardly field a single RCVS Recognised Specialist amongst its numbers. There were also concerns being voiced about the terms under which referral practices could join the network.
However, the underlying challenge of keeping pet insurance affordable remains. RSA says that according to its research, and based on Association of British Insurers averages, 27% of its customers pay more for their pet insurance than the average cost of home insurance; 17% pay more than the average cost of car insurance and 3% pay more than the average cost for private medical insurance.
It does seem as though RSA has been making a concerted effort to adopt a more collaborative approach before the nationwide rollout, having meetings with both the BVA and BSAVA which the respective organisations described as 'constructive'.
The current state of play is that RSA is inviting referral practices to join its network in advance of a launch some time after the end of the year. Thereafter, VetSurgeon.org understands that clients who decide to opt for a non-emergency referral outside its network will be subject to an additional flat fee which has yet to be announced.
Bill Paton, Claims Director for UK and Western Europe said: “The introduction of this new preferred referral network ensures that our customers will receive the most appropriate available treatment as diagnosed by their vet.
"For us, being able to control costs with our vet partners in the network will help us manage our claims cost more effectively and ensure that policy limits last as long as possible.
"Ultimately, this will have a positive effect on premium rates for our customers ensuring that pet insurance remains affordable.”
For more information about joining RSA's referral network, email: rsa.pet@uk.rsagroup.com.
International Cat Care has announced the winners of four new ‘Easy to Give’ awards and three ‘Cat Friendly’ awards.
The Easy to Give award was created to reward pharmaceutical companies whose products are easy to administer to cats. Previous examples have included drugs in a highly palatable form, smaller tablets, longer lasting preparations or those with an easier mode of administration.
Easy to Give winners this year are Virbac's Prinovox (ectoparasiticide), Norbrook's Loxicom (NSAID), and Ceva's Vectra Felis (ectoparasticide) and Zodon (antibiotic).
These latest winners bring the total number of Easy to Give awards presented, since their inception in 2005, to 35.
International Cat Care CEO, Claire Bessant, said: ‘It is so important that cats receive treatments prescribed for them, whether it is for preventive care or to treat a problem. If a drug is too difficult to get into the cat, owners often fail to complete the course, leaving the cat inadequately treated – as we worry about antibiotic resistance, this is particularly important beyond the individual animal too. Struggling with a cat to medicate can put a tension into the owner/cat relationship at a time when owners feel they want to be more supportive rather than seen as something to fear. This year we asked those trying the products if the act of medication had a negative effect on their relationship with their cat, as many people find that in the struggle to medicate, often the cat becomes fearful or aggressive towards them which owners also find very distressing. This kind of innovation by pharmaceutical companies is essential to feline health.’
Easy to Give awards are confined to prescription only medicines (POMs) or methods of delivering POMs. International Cat Care also recognises other products which have made a difference to cat wellbeing and welfare, with its Cat Friendly Awards.
The Cat Friendly Awards go to the SoftE Smart Collar from MDC, the SureFeed Microchip Pet Feeder from SureFlap and the Cat Carrier Tree from Royal Canin.
For more details on the work of the charity go to www.icatcare.org.
Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle1.
In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with 41% in 2013.
According to Dr Tim Potter MRCVS from Westpoint Veterinary Group, Mycoplasma bovis has emerged as an important pathogen of calves worldwide2. He said: "It is associated with a number of clinical presentations including respiratory disease, otitis media and arthritis.
"The role of Mycoplasma bovis in pneumonia is well established and there are a number of reports in the literature of respiratory disease outbreaks where it was the predominant bacterium isolated. However, as with most causes of pneumonia, colonisation by Mycoplasma bovis alone is not always sufficient to cause disease and it may present in combination with other respiratory pathogens."
For other pathogens, the surveillance found 83% of samples positive for Para-influenza 3 virus (Pi3v), 76% Bovine Respiratory Syncytial virus (BRSv), 32% IBR, and 25% for BVD. Apart from BVD, which saw a three-point reduction from 28% the previous year - these show little change from 2013.
According to Zoetis vet Carolyn Hogan, in pneumonia outbreaks involving Mycoplasma bovis, many of the clinical signs are similar to those caused by other pneumonia pathogens: coughing, raised temperature, rapid breathing and lethargy.
She said: "This can make it difficult for farmers and vets alike to identify Mycoplasma bovis as a possible cause of disease based on clinical signs alone, unless calves are also showing some of the other distinguishing signs associated with Mycoplasma infection.
"These include ear infections, head shaking or tilting, and arthritis. Poor response to treatment, with resulting chronic respiratory cases, may also be suggestive of Mycoplasma infection. For a definitive diagnosis, of course, analysis of blood or respiratory tract mucous is required."
Whilst vaccination protection is available against the viruses (BRSv, Pi3v, BVD and IBR) and Mannheimia (Pasteurella) haemolytica, Carolyn points out that there is no ‘off the shelf’ vaccine available for Mycoplasma bovis. She adds that treatment can be challenging due to the insidious nature of disease, and lack of effectiveness of some antibiotics.
Once Mycoplasma bovis is present on a farm, Carolyn cautions that eradication can be very difficult. "It can be transmitted in milk from carrier cows, and in saliva among calves, particularly when multiple animals suckle the same teat feeders.
"Minimising this pathogen's impact on health and productivity relies on reducing its exposure to susceptible animals and maximising their resilience against it. For a comprehensive programme of control measures, farmers should consult their vet."
Carolyn suggests that such a programme is likely to include: testing the farm's Mycoplasma bovis status; effective biosecurity; not feeding infected milk; ample ventilation for adults and youngstock alike; rapid spotting of sick animals, isolation and vet-prescribed treatment; vigilance for poor response to treatment and development of chronic cases; vaccination against main viral pneumonia pathogens; and low stress through good stockmanship.
References
Photo: By Y tambe (Y tambe's file) [GFDL, CC-BY-SA-3.0 or CC BY-SA 2.5-2.0-1.0], via Wikimedia Commons
Bayer Animal Health has announced the launch of three new educational videos which look at some common concerns in the profession about antimicrobials, including owner compliance, laboratory testing, and prescribing policies in different clinical scenarios.
The videos follow research conducted by Bayer as part of its Veraflox What Lies Beneath campaign in which 73% of veterinary surgeons cited owner compliance as a frequent cause of treatment failure when tackling bacterial infections, and only 5%1 of vets said that they send samples for culture and sensitivity testing routinely in cases where they suspect bacterial involvement.
In the first video presentation, Matt Jones, Microbiology Manager at IDEXX Laboratories, focuses on the importance of culture and sensitivity testing, and how to interpret results from these tests. Matt discusses the merits and drawbacks of various testing techniques available, both in-house and from external laboratories.
In the second presentation, Liz Watkins, founder of Chunk Training, a veterinary training provider which specialises in customer service, provides communication tips to improve consultation technique and increase owner compliance when a course of antimicrobials has been prescribed.
In the final presentation, Ian Battersby, Recognised Specialist in Small Animal Internal Medicine at Davies Veterinary Specialists answers commonly asked questions submitted by vets about antibiotics. Questions include how to adopt a practice antimicrobial policy, how to decide when it is appropriate to use antibiotics in GI disease and how to approach cases that are not responding as expected to antimicrobial treatment.
Hannah Watts, Group Product Manager at Bayer said: ‘‘The issues highlighted by the research need to be addressed in order to help promote responsible antimicrobial use. One of the key findings from the survey was the relatively low number of culture and sensitivity tests that are routinely performed. This may in part be due to financial constraints, but in addition to assisting in appropriate antimicrobial selection, culture and sensitivity tests often save money for the client in the long run, as well as helping to resolve the condition as quickly as possible, leading to improved treatment outcomes for the pet.‘’
Watching the videos can be used to count towards your annual CPD requirement. They're now available at www.vetcentre.bayer.co.uk.
The BVA has announced the results of a survey which found that 64% of small animal veterinary surgeons have been injured in the line of duty in the past year alone.
By far the most common injuries were scratches and bites (90% and 78% respectively), however 17% rated their injuries as either 'quite' or 'very' severe.
Whilst small animal vets were shown to be at the greatest risk of injury in clinical practice (compared to 61% of equine vets and 53% of production animal vets), the injuries sustained by production and equine vets were predictably more severe. 19% of production vets and 27% of equine vets rated their injuries as either 'quite' or 'very' severe.
BVA President John Blackwell said: Vets accept the daily risk of injury at work, but these figures highlight just how common injuries are for vets who care for pets. Rather than simply accepting this as an ‘occupational hazard’, veterinary teams should ensure they are taking all appropriate measures to mitigate the risks of working with animals whenever possible. BVA provides guidance for vets, for example on preventing and dealing with dog bites in the practice."
Improve International has announced that it is to hold the first conference aimed specifically at Official Veterinarians.
Taking place from 22-23 October 2015, Improve says the conference aims to provide a forum to update OVs on the latest developments and thinking on all aspects of OV work and to provide an opportunity to network and share experiences and ideas.
Organised in association with the Animal & Plant Health Agency (APHA), the Official Veterinarian Conference programme includes a two-day stream of large animal lectures and round-table discussions on topics including Bovine TB, Brucellosis, Anthrax, Sheep Scab and other important diseases.
A lecture stream for small animal practitioners will provide updates on export regulations and small animal exotic diseases, with dedicated lectures for equine practitioners also running on Friday 23 October.
Speakers at the event include Peter Jinman, Chair of the RCVS Certification Sub-Committee (pictured right); Dr Tim Brazil, Directorate of Equine Medicine on the Move and Andy Paterson, Veterinary Head of Intervention Epidemiology. An exhibition of the latest products and services for OVs will run alongside the conference which takes place at the Alexandra House Hotel and Conference Centre, near Swindon, where Improve International is based.
David Babington MRCVS, Managing Director of Improve, said: "The world of the OV is a fast-changing one so this unique event provides an opportunity for OVs to come together in a relaxed atmosphere to hear industry experts deliver up-to-date and practical lectures which will have a positive impact on their work as an OV.
"The programme and content has been developed by our Scientific Committee in collaboration with APHA which is supporting us and we believe it will offer highly relevant content for all OVs."
Are you planning to come to this event? If so, indicate it here, so other VetSurgeon members can see you'll be there!
To book, visit www.officialvet.com
European Specialist in Veterinary Dentistry Lisa Milella, who revealed last year that she has been diagnosed with motor neurone disease, has now announced that she plans to end her life at the Swiss-based organisation, Dignitas, and is calling on MPs to support a Private Members Bill on assisted dying, due for a second reading next month.
Speaking to the Daily Mail, Lisa said: "In Britain, we give more dignity in death to our pets than we do human beings. I don't want to suffer a prolonged, lingering death. I want to be able to choose when I die – and I'd like to do that in my home, surrounded by my loved ones with dignity – but British law doesn't allow me to do that and that makes me angry."
Meanwhile, Lisa's campaign to raise money for International Animal Rescue has smashed its original target of £10,000 and now stands at £24,096.83, with a new target of £50,000.
Virbac has launched Cooldent, described as a highly palatable, fast-acting tablet to freshen dogs' breath.
Claire Lewis, Product Manager, explained: "Bad breath in dogs is unpleasant and is most frequently caused by a build-up of plaque and calculus on their teeth.
"Cooldent's natural ingredients have an anti-plaque action and help both to maintain a balanced intestinal flora and to reduce gas production. They also help to freshen dogs’ mouths by contributing to the reduction of volatile compounds, produced by bacteria which can cause halitosis."
She added: "We are delighted to add Cooldent to our comprehensive dental range, alongside our VeggieDent, natural, all-vegetable, highly palatable teeth-cleaning chews for dogs and Vet Aquadent, an easy-to-use drinking water additive which helps to fight dental plaque and tartar formation in dogs and cats."